PharmaTher Holdings Ltd.
PHRM
CNSX
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -28.91% | 38.40% | -14.19% | 5.48% | -16.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.51% | 32.20% | -20.66% | -64.07% | -76.75% |
| Operating Income | 0.51% | -32.20% | 20.66% | 64.07% | 76.75% |
| Income Before Tax | -15.35% | -9.86% | 4.37% | 65.53% | 72.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.35% | -9.86% | 4.37% | 65.53% | 72.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.35% | -9.86% | 4.37% | 65.53% | 72.25% |
| EBIT | 0.51% | -32.20% | 20.66% | 64.07% | 76.75% |
| EBITDA | -- | -32.17% | 20.69% | 64.08% | 76.75% |
| EPS Basic | -12.90% | -10.00% | 6.45% | 65.91% | 72.57% |
| Normalized Basic EPS | -6.25% | -42.11% | 14.29% | 63.04% | 77.14% |
| EPS Diluted | -12.90% | -10.00% | 6.45% | 65.91% | 72.57% |
| Normalized Diluted EPS | -6.25% | -42.11% | 14.29% | 63.04% | 77.14% |
| Average Basic Shares Outstanding | 2.71% | 0.14% | 0.40% | 0.40% | 0.40% |
| Average Diluted Shares Outstanding | 2.71% | 0.14% | 0.40% | 0.40% | 0.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |